Celgene Share Price

CELG

Delayed Nasdaq 21:00:00 20/11/2019 GMT			5-day change	1st Jan Change
108.24 ^USD	+0.10%		-1.97%	+68.89%

14/06/23	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
08/09/21	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

News in other languages: Celgene

07/04/21	DGAP-WpÜG: Angebot zum Erwerb / Zielgesellschaft: ; Bieter: qqqqq
25/03/21	Leonteq wird neue Emittentin an der BX Swiss AG im Segment «deriBX»
02/02/21	BX Swiss AG startet Handel in neuem Bondsegment
07/07/20	Die BX Swiss AG erhält von der FINMA die Zulassung zur Führung des Schweizer Beraterregisters
03/07/20	Möbel Markt mömax wird neuer Ankermieter im Rüti Center in Pratteln

More news

Celgene Corporation specializes in the design, development, and sale of products for treating cancer and immune system disorders. Net sales break down by product family as follows: - therapeutic products (99.9%); - other (0.1%): cellular therapy products and biological materials for implants, for tissue and organ treatments, and for therapeutic product development. Net sales are distributed geographically as follows: the United States (65.6%), Europe (24.7%) and other (9.7%).

Employees

Sector

More about the company

Market Cap	77.04B 69.81B 64.57B 58.26B 110B 7,264B 114B 776B 308B 3,880B 289B 283B 12,316B	P/E 2017	28.7x	P/E 2018	11.6x
Enterprise Value	91.26B 82.7B 76.49B 69.01B 130B 8,604B 135B 919B 364B 4,596B 342B 335B 14,590B	EV / Sales 2017	6.61x	EV / Sales 2018	3.86x
Free-Float	-	Yield 2017 *	-	Yield 2018	-

14/06/23	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
08/09/21	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI
22/06/21	Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celgene's Patents Required to Manufacture and Sell Certain Limited Quantity	CI
22/02/21	Celgene Corporation Issues Notice of Redemption of Notes	CI
04/02/21	Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion	CI
04/01/21	Ikena Oncology, Inc. announced that it has received $120 million in funding from a group of investors	CI
22/12/20	Amgen : Signs Licensing Agreement With Medicines Development for Global Health	MT
05/11/20	Bristol Myers Squibb : Q3 Results Beat Estimates; Raises 2020 EPS Outlook	MT
22/09/20	Silverback Therapeutics, Inc. announced that it has received $84.999996 million in funding from a group of investors	CI
21/09/20	Silverback Therapeutics, Inc. announced that it expects to receive $84.999996 million in funding from a group of investors	CI
25/03/20	Agios Pharmaceuticals, Inc. Provides Update on 2016 Collaboration Agreement with Celgene	CI
10/03/20	Silverback Therapeutics, Inc. announced that it has received $68.400013 million in funding from a group of investors	CI
04/03/20	Pulmonary Fibrosis Foundation Launches Industry Consortium to Identify Biomarkers in Pulmonary Fibrosis	CI

28/02/23	BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	AQ
25/08/22	Not What The Doctor Ordered: Authorisation Application Withdrawn For Pharma Patent Settlement In Australia	AQ
29/07/22	Authorisation request for proposed settlement between pharmaceutical companies withdrawn	AQ
24/02/22	BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)	AQ
04/08/21	Celgene : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid®)	AQ

	2017	2018
Net sales	13B 11.78B 10.9B 9.83B 18.53B 1,226B 19.18B 131B 51.91B 655B 48.8B 47.76B 2,079B	15.28B 13.85B 12.81B 11.56B 21.78B 1,441B 22.55B 154B 61.01B 770B 57.35B 56.13B 2,443B
Net income	2.94B 2.66B 2.46B 2.22B 4.19B 277B 4.34B 29.6B 11.74B 148B 11.03B 10.8B 470B	4.05B 3.67B 3.39B 3.06B 5.77B 381B 5.97B 40.74B 16.15B 204B 15.18B 14.86B 647B
Net Debt	3.79B 3.44B 3.18B 2.87B 5.41B 358B 5.6B 38.19B 15.14B 191B 14.23B 13.93B 606B	14.22B 12.89B 11.92B 10.75B 20.27B 1,341B 20.98B 143B 56.78B 716B 53.37B 52.24B 2,274B

Celgene Share Price

Stocks

CELG

Valuation: Celgene

Latest news: Celgene

Press Releases: Celgene

News in other languages: Celgene

Quotes and Performance

Financials

Company Profile